Schedule 13G ownership disclosure

Jade Biosciences Inc

Common Stock, $0.0001 par value · CUSIP: 008064206

Event date: 2025-04-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 3,220,369.00 · Class: 9.9%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 3,220,369.00 · Class: 9.9%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 3,220,369.00 · Class: 9.9%

  • VHCP Management III, LLC

    Shares: 3,220,369.00 · Class: 9.9%

  • VHCP Management EG, LLC

    Shares: 3,220,369.00 · Class: 9.9%

  • Nimish Shah

    Shares: 3,220,369.00 · Class: 9.9%

  • Bong Y Koh

    Shares: 3,220,369.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-011957
Form type
SCHEDULE 13G
Filer
Jade Biosciences, Inc.
CIK
CIK 1798749
Filed
May 05, 2025
Reporting period
Apr 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub